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Protein receptor-independent 
plasma membrane remodeling  
by HAMLET: a tumoricidal protein-
lipid complex
Aftab Nadeem1, Jeremy Sanborn2, Douglas L. Gettel2, James Ho C. S.1,3, Anna Rydström1, 
Viviane N. Ngassam2, Thomas Kjær Klausen4, Stine Falsig Pedersen4, Matti Lam1, 
Atul N. Parikh2,3 & Catharina Svanborg1
A central tenet of signal transduction in eukaryotic cells is that extra-cellular ligands activate specific 
cell surface receptors, which orchestrate downstream responses. This ‘’protein-centric” view is 
increasingly challenged by evidence for the involvement of specialized membrane domains in signal 
transduction. Here, we propose that membrane perturbation may serve as an alternative mechanism 
to activate a conserved cell-death program in cancer cells. This view emerges from the extraordinary 
manner in which HAMLET (Human Alpha-lactalbumin Made LEthal to Tumor cells) kills a wide range 
of tumor cells in vitro and demonstrates therapeutic efficacy and selectivity in cancer models and 
clinical studies. We identify a ‘’receptor independent” transformation of vesicular motifs in model 
membranes, which is paralleled by gross remodeling of tumor cell membranes. Furthermore, we find 
that HAMLET accumulates within these de novo membrane conformations and define membrane 
blebs as cellular compartments for direct interactions of HAMLET with essential target proteins such 
as the Ras family of GTPases. Finally, we demonstrate lower sensitivity of healthy cell membranes to 
HAMLET challenge. These features suggest that HAMLET-induced curvature-dependent membrane 
conformations serve as surrogate receptors for initiating signal transduction cascades, ultimately 
leading to cell death.
Lipids alone suffice to produce closed, flexible bilayer membranes that isolate cellular interiors from the 
extra-cellular space1. A unique combination of material properties characterizes membrane elasticity2, 
including large volume compressibility (109 to 1010 N/m2), area expansion (102 to 103 mN/m) and low 
bending rigidities (10−19 Nm). As a result, the vesicular membrane is highly resistant to compression and 
expansion in surface area but highly susceptible to bending-mediated deformations and shape transfor-
mations3,4. In the context of a living cell, these gross morphological shape changes are not a passive con-
sequence of cellular activity, but present de novo membrane conformations, which are actively modulated 
during a variety of cellular responses5,6. Despite the widespread appreciation of membrane conformations 
in general, how they affect ligand binding, such as during signal transduction, is largely unknown.
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Lipid membranes can potentially provide the cell with alternative mechanisms for sensing and bind-
ing external ligands. Ligand binding can modulate membrane properties, such as through morphological 
remodeling and/or spatial compositional reorganization, which can be translated by the cell into the 
biochemical language of signal transduction. For example, the binding of BAR domain superfamily and 
the COPII coat proteins mold membrane domains into highly specific, well-defined shapes and sizes7–12. 
BAR domains perform diverse functions, including de novo generation and sensing of membrane curva-
ture for recruitment of cytosolic factors to differently shaped membrane structures, tenth of nanometer 
in size. COPII coat proteins favor nanometer-sized vesicles (60 nm–300 nm), depending on the types of 
recruited coat proteins and the availability of different cargo proteins13. In addition, exogenous ligands 
such as Shiga toxin (STX) may introduce sub-micrometer membrane invaginations, characterized by 
negative curvature in lipid organization, thereby deforming cell membranes14,15. In this case, one STX 
B-subunit molecule binds up to fifteen extracellular oligosaccharide receptor domains presented by the 
Gb3 membrane glycosphingolipids16.
The HAMLET complex is derived from human α -lactalbumin (HLA) – a major protein component 
in breast milk (2 mg/ml), which is a coenzyme in lactose synthase. In HLA, a large α -helical domain is 
separated from a small β -sheet domain by a deep cleft, which contains a disulfide bridge coordinating 
a Ca2+ binding loop at the junction of the two domains17–19. When the strongly bound Ca2+ is released, 
HLA adopts a partially unfolded conformation and this conformer binds a discrete number of oleic acid 
molecules, predominantly in the deprotonated oleate form, producing the long-lived, kinetically trapped 
HAMLET complex20. HAMLET’s mechanism of tumoricidal action is thought to involve a multi-step 
process. Shared by a broad variety of tumor cells, the process involves (1) cell-surface binding21; (2) ion 
flux activation22 (3) cytosolic uptake leading to intracellular interactions with kinases and GTPases23, 
resulting in broad inhibition of multiple signaling pathways and (4) eventual translocation to the cell 
nucleus, where HAMLET interacts with histones and disrupts the chromatin structure24.
This study examined if the insertion of HAMLET alone can achieve membrane remodeling, without 
engaging specific cell-surface receptors. We present evidence that HAMLET transforms the vesicular 
motif in model membranes into a dense tangle of tubules and grossly remodels plasma membranes of 
tumor cells, generating a positive membrane curvature, culminating in membrane protrusions and blebs. 
We also show that such membrane blebs provide a new, flexible compartment for HAMLET to access 
critical cellular constituents, notably several activated Ras family proteins on the cytoplasmic face of the 
plasma membrane and inhibit their downstream activity. Finally, we show that these responses are absent 
in healthy primary cells, which resist the tumoricidal effects of HAMLET. Membrane integration and 
perturbation thus provides HAMLET direct access to mechanisms that initiate and drive intracellular 
processes crucial for survival.
Results
HAMLET induces massive tubulation of lipid bilayers. To address if the biological response to 
HAMLET involves physical membrane remodeling, we first employed protein- and cytosol-free giant 
unilamellar vesicles (GUVs). The use of GUVs, tens of micrometers in diameter enables real-time visu-
alization of HAMLET-induced dynamics of membrane perturbations using fluorescence microscopy. For 
visualization, synthetic GUVs25 consisting of a single phospholipid (POPC, 1-palmitoyl 2-oleoyl-sn-1-
glycero-3-phosphocholine) are doped with 1.0–2.0 mol% of a phase sensitive probe (1,2-dioleoyl-sn-glyce-
ro-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (Rho-DOPE)26. Suspensions of GUVs 
containing 300 mM sucrose in an osmotically balanced glucose bath were produced by established elec-
troformation methods27.
Using spinning disc confocal fluorescence microscopy, we found that administering HAMLET 
(30–200 μ M) to a population of GUVs prompted a highly dynamic gross membrane remodeling 
(Supplementary Movie S1A-C). Within seconds, the vesicle assumed a tense spherical shape and within 
the first hundreds of seconds – some vesicles appeared tubulated, others intact, and still others, with 
internal membranes (Fig. 1A–D). One of the most striking and frequent changes involved vesicles pro-
ducing a bundle of fluctuating tubules. Immediately after the addition of HAMLET, the tense spheri-
cal shape of the vesicle was replaced by an oblate structure, likely reflecting the initial integration of 
HAMLET into the membrane (Fig. 1A,B). Concomitantly, membrane tubules began to emanate from the 
region of the GUV with the highest curvature. Subsequently, the lumen of the vesicle shrank and tubules 
grew up to several micrometers in length, until the GUV was transformed into a rapidly fluctuating bun-
dle of tubes (Fig. 1C,D). The tubules in the bundle were several micrometers long, had diameters near 
the optical resolution, and exhibited uniform fluorescence intensity consistent with a defined thickness 
of the tubules. The time scale of the tubulation ranged from several seconds to several tens of minutes 
depending on the concentrations of HAMLET administered. Even in single experiments, the process was 
asynchronous and stochastic with some GUVs transforming into tubules within seconds and others more 
slowly (minutes). Ultimately, all GUVs transformed into tubes, however.
Membrane integration of HAMLET in GUVs. To determine the fate of the HLA protein in HAMLET, 
we employed fluorescently labeled, AlexaFluor® 568 HAMLET (Alexa-HAMLET), in which the fluoro-
phore was conjugated to HLA via primary amine side chains. GUV experiments, performed using a 
stained lipid phase (Oregon Green 488 DHPE), revealed that the majority of Alexa-HAMLET, and hence 
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Figure 1. HAMLET induces GUV tubulation. (A) Selected equatorial stills from time lapse spinning disk 
confocal fluorescence images [see Supplementary Movie S1] obtained after incubating POPC GUVs in 
30 μ M HAMLET. Panels illustrate key steps during the transformation of spherical vesicles into bundles of 
fluctuating tubules (21 seconds). Fluorescent intensities depicted in false color. Scale bar, 10 μ m. (B) Cartoon 
depicting the two transformation sequences in (A). (C) Plot of the change in GUV diameter over time 
showing two regimes of shrinkage (rate = − 1.846 ± 0.5 μ m/s). Systematic errors in measurements of GUV 
properties are shown. Estimates for diameters are approximate because of deviations from spherical shapes. 
(D) Kinetics of tubule formation showing growth in the number of tubules over time as GUV shrinkage 
occurs (see methods for calculation). For tubulation kinetics in a population of vesicles, see Supplementary 
Movie S1.
www.nature.com/scientificreports/
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HLA, (> 90%) accumulates at the periphery of the membrane tubules (Fig.  2A–C and Supplementary 
Movies S5–S7). These results confirm that the protein in HAMLET does not partition into any pre-existing 
membrane evaginations, but rather it is directly responsible for inducing curvature-generating mem-
brane deformations.
Figure 2. HAMLET interacts with GUVs and triggers ion fluxes across the membrane. (A) Selected 
equatorial stills from a time lapse spinning disk confocal image sequence of a POPC GUV (Oregon Green 
488) exposed to 30 μ M Alexa-HAMLET [see Supplementary Movies S5, S6 and S7]. Scale bar, 20 μ m.  
(B) (i) Merge (ii) Lipid labeled Oregon Green 488 DHPE and (iii) Alexa Fluor 568 colocalize within the 
tubular deformations of the GUVs. Scale Bar, 60 μ m. (C) Fluorescence intensity of (b) sampled on the 
tubule, the perimeter of the GUV, the exterior & interior solutions. Normalized fluorescence intensity was 
calculated dividing each number by the highest fluorescence value. (D) Confocal microscopy images of the 
incubation of model membrane GUVs with HAMLET individual component compared to untreated control. 
Scale bar, 10 μ m. (E) HAMLET (35 μ M) induces sodium influx in artificial liposomes compare to HLA 
(35 μ M) and oleate (175 μ M) that showed no significant influx.
www.nature.com/scientificreports/
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To address whether the spherical-to-tubular membrane morphological transition was unique to 
HAMLET, we carried out experiments in which the individual HAMLET components HLA, oleic acid 
and sodium oleate were administered at comparable concentrations (Fig.  2D). In the case of HLA, no 
detectable morphological change was evident (Supplementary Movie S2). Oleic acid and oleate did not 
induce external tubulation in the GUVs. However, qualitatively different, internal tubules or invagina-
tions were observed (Supplementary Movies S3-S4), comparable to those reported previously28,29. These 
results confirm the need for both protein and lipid for HAMLET to produce the external tubulation 
response in the GUVs.
HAMLET induces membrane permeabilization in GUVs. To address if model membranes are 
permeabilized by HAMLET, we quantified ion fluxes across the membranes of small artificial liposomes, 
exposed to a change from 4mM to 204 mM of NaCl in extra-vesicular concentration, Sodium Green 
fluorescence was used as readout for the influx of externally added sodium ions (Fig. 2E). Artificial lipos-
omes were produced by mixing 1,2-dioleoyl-sn-glycero-3-phospho-(1′ -rac-glycerol) (DOPG) and Egg 
yolk L-α -phosphatidylcholine (EYPC) in a 1:1 ratio. HAMLET triggered a rapid influx of Na+ ion into 
the liposomes but neither HLA nor oleic acid had this effect at concentrations equimolar to HAMLET.
To further characterize the effects of HAMLET on membrane integrity, GUVs were incubated with 
fluorescent, NBD-glucose (58 μ M), which does not permeate unperturbed GUVs. After the addition of 
HAMLET (30 μ M), the onset of tubulation did not coincide with the translocation of NBD-glucose into 
the interior of the tubulating vesicle, suggesting that tubulation per se did not lead to global destabili-
zation of the membrane. It was only after the collapse of the entire vesicular motif, that we witnessed 
loss of compartmental integrity as seen by the leakage and homogenization of NBD labeled glucose 
(Supplementary Figure S1A,B). The results suggest that the membrane leakage profile is specific to 
HAMLET and not reproduced by its subcomponents, HLA and oleic acid.
Membrane perturbations in tumor cells exposed to HAMLET. Unlike GUVs, the organization 
and behavior of lipids in cytoplasmic membranes is constrained by interactions with other constituents, 
such as membrane proteins and the cytoskeleton5. To address if the tubulation response observed in the 
GUVs has a biological correlate, lung carcinoma cells in suspension were exposed to Alexa-HAMLET 
and followed by live cell imaging for 5–10 minutes. Rapid membrane tubulation was detected around 
the cell periphery (Supplementary Figure S2A,B). The tubules showed positive Alexa-HAMLET staining, 
compatible with membrane integration of HAMLET into the newly formed tubules (Fig. 3A).
The involvement of lipids in the response of tumor cell membranes was addressed, using GUVs made 
from tumor cell lipid extracts (TCLE). The TCLEs formed GUVs with diameters of 10–30 μ m, compara-
ble to those obtained using single purified POPC. The TCLEs formed tubules with kinetics similar to the 
POPC GUVs, resulting in the shrinkage of the vesicular lumen (Fig. 3B,C and Supplementary Movie S8). 
The first tubules appeared to emanate from areas of lipid accumulation in the GUV membranes. The 
results suggest that despite the more complex lipid composition, HAMLET triggers similar membrane 
responses also in tumor cells.
In addition to tubulation, HAMLET induced gross membrane deformations in A549 lung carcinoma 
cells, characterized by the appearance of small circular membrane blebs at the cellular periphery, which 
increased in number during the first 2 minutes. Over the next 5 minutes, the blebs merged, successively 
increasing in size. After 7 minutes, > 80% of tumor cells were affected (Fig.  3D, Supplementary Figure 
S3A–D and Supplementary Movie S9). The bleb compartments were either polarized or arose around the 
perimeter of the cells, similar to the deformations found in the GUV model membranes (Fig. 1). Control 
experiments confirmed that no such blebbing occurred when HAMLET was substituted for the native 
protein or oleic acid alone (Fig. 3D).
Membrane blebs creates a new compartment for the interaction of HAMLET with cellular 
targets. The change in cell morphology suggested that membrane blebs might create a new functional 
compartment for extracellular ligands like HAMLET to interact with specific cellular targets (Fig.  3E). 
This hypothesis was addressed by confocal imaging experiments and Ras GTPases were selected as model 
targets for HAMLET in this analysis. We have recently shown that HAMLET specifically recognizes 
this family of GTPases and perturbs their function30. Of 16 Ras family proteins that were targeted by 
HAMLET in vitro, 14 (87.5%) can be stably membrane anchored because of post-translational lipidation 
of cysteine residues at the CAAX motif31.
To address if the integration of HAMLET into the membrane blebs might facilitate interactions with 
activated Ras, lung carcinoma cells were exposed to Alexa-HAMLET (35 μ M) and the cells were coun-
terstained for the 16 Ras family proteins. Rapid accumulation of Ras proteins in membrane blebs was 
detected after 15 minutes (Fig. 4 and Supplementary Figure S4,S5). RasL11B, a recently discovered Ras 
family member, whose function has not been characterized, showed a clear redistribution to membrane 
blebs around the cellular periphery, as did RhebL1, which regulates mTOR signaling, and Rap1B, which 
is involved in proliferation. Ras was clustered in a few larger membrane protrusions. Braf also showed 
rapid accumulation in the membrane blebs, as did ArfGAP3, Rab3C and Arl5A. Raf1, which is a Braf 
homologue controlling signaling downstream of Ras and the Ras activator Rasgrp3, showed staining 
both at the membrane and throughout the cells (Supplementary Figure S4–S6).
www.nature.com/scientificreports/
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Figure 3. HAMLET interacts with tumor cell membrane (A) Alexa-HAMLET accumulates at the cell 
membrane at 4 °C with clear evidence of tubulation. Scale Bar, 5 μ m (B) Fluorescence microscopy images 
of GUVs formed from A549 lung carcinoma lipid extract (see methods for details) incubated with 30 μ M 
HAMLET (2 seconds between frames). Scale Bar, 10 μ m. (C) Plot of diameter of vesicle lumen over time, 
which begins to shrink approximately 16 mins after addition of HAMLET to the GUV exterior. Systematic 
errors in measurements of GUV properties are shown. Estimates for diameters are approximate because of 
deviations from spherical shapes. (D) Kinetics of membrane protrusion formation in lung carcinoma cell 
exposed to HAMLET (35 μ M). Scale Bar, 5 μ m Right panel: Cartoon diagram of (D). Bottom panel: shows 
no significant change in tumor cell morphology in cells treated with HLA (35 μ M) and oleic acid (175 μ M) 
alone. (E) Alexa-HAMLET accumulates in tumor cell blebs. Scale Bar, 10 μ m.
www.nature.com/scientificreports/
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Figure 4. Accumulation of Ras family proteins in membrane protrusions. (A) Ras, RasL11B, RhebL1 
and Rap1B (green) accumulate in membrane blebs, 15 minutes after HAMLET challenge (35 μ M). Arrows 
indicates blebbing structures, B = blebs, C = Cytoplasm. (B) Alexa-HAMLET (red) shows a similar pattern 
of membrane localization. (C) Merged confocal images. Untreated cells are shown in the bottom panel. 
R = Pearson coefficient for co-localization. Scale bar, 5 μ m.
www.nature.com/scientificreports/
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The results suggest that membrane blebs formed in response to HAMLET, provide a new compart-
ment, spatially confining HAMLET in the vicinity of critical signaling clusters, exemplified by Ras family 
proteins.
Lack of membrane tubulation, blebbing or Ras accumulation in healthy, differentiated 
cells. Healthy, differentiated cells are more resistant to HAMLET than lung carcinoma cells and main-
tain their viability. If membrane perturbations characterize the tumor cell response to HAMLET, we 
would not expect membrane changes to occur in healthy primary cells. To address this question, small 
airway lung epithelial cells, in primary culture, were exposed to HAMLET and the membrane response 
was monitored by real-time confocal microscopy, for 20 minutes (Fig.  5A). Membrane tubulation was 
not detected and membrane blebs were not formed, in contrast to the tumor cells, where membrane 
changes occurred almost instantaneously. HAMLET bound to the membranes of the SAE cells without 
evidence of tubulation (Supplementary Figure S7), indicating that the membrane perturbation is the 
decisive factor and not HAMLET recognition per se. Furthermore, the redistribution of Ras proteins 
differed markedly from that in tumor cells. Rather than membrane accumulation, Ras, RasL11B and 
RasL12 were redistributed from the membrane of untreated SAE cells to intracellular compartments 
(Fig. 5B,C and Supplementary Figure S8,S9). Inhibition of Ras activity by HAMLET in lung carcinoma 
cells was demonstrated by co-immunoprecipitation of active Ras with the Ras-binding domain of Raf1. 
In contrast, no effect of HAMLET on Ras activity was recorded in healthy, differentiated cells (Fig. 5D).
As the Ras GTPases are critical for cell proliferation and survival, these observations support the 
notion that membrane responses to HAMLET may influence the difference in susceptibility and cell 
death.
Discussion
HAMLET is a protein-lipid complex with broad tumoricidal activity and therapeutic efficacy in tumor 
models and clinical studies. The broad-spectrum efficacy of HAMLET in killing vastly different tumor 
cells suggests that HAMLET must target molecules that are prevalent in tumor cells and that control con-
served cell-death pathways. To this end, a discrete and susceptible target is the lipid bilayer component 
of the tumor cell membrane. But how HAMLET binds the exoplasmic leaflet of the cell membrane and 
how it affects the cellular membrane has largely been unknown. Previous studies purportedly examining 
HAMLET-membrane interactions suggest pore formation in model membrane monolayers32, as well 
as morphological distortions, loss of structural integrity, and permeabilization in bilayers and tumor 
cells21,33. In the absence of real-time dynamic measurements, these observations do not lend themselves 
to a unifying view on the types (and mechanisms) of membrane morphological remodeling induced by 
HAMLET.
The appearance of tubules in giant vesicles devoid of proteins or energy generating machinery sug-
gests that the insertion of HAMLET itself is sufficient to trigger tubulation. Unlike surface docking of 
proteins at high concentrations that generate crowding in domain-forming membranes or intracellular 
and endogenous scaffolding proteins such as COPII or BAR proteins, which act both as sensors and 
inducers of membrane curvature8,13, HAMLET is a more complex exogenous curvature generator, acting 
through membrane insertion from the extracellular space. We propose that the appearance of tubular 
extensions is a direct consequence of the insertion of both the partially unfolded protein and multiple, 
amphiphilic oleic acid ligands into the membrane, which creates conditions for the generation of local 
spontaneous curvature, as described previously for multi-anchoring polymer34. It thus appears that the 
lipid membrane itself can provide the cell with mechanisms for sensing external ligands and translating 
physical processes into the language of signal transduction.
Assuming HLA to oleic acid stochiometry to be between 1: 4 and 1: 6 in HAMLET, we estimated the 
concentrations of pure components that mimic those delivered by HAMLET to be 175 μ M for oleate and 
30 μ M for HLA for 30 μ M HAMLET concentration. Conducting experiments using these concentrations 
of oleic acid (175 μ M), sodium oleate (175 μ M), and HLA (30 μ M), we find that individual components 
do not reproduce the deformations (i.e., generation of tubular evaginated protrusions); even concen-
trations as high as 500 μ M failed to produce comparable tubules. Specifically, HLA fails to produce any 
observable deformations and OA and sodium oleate induces internal (rather than external) tubulation – 
albeit to a limited and variable extent. We reason that this dramatic disparity in the effects of HAMLET 
and pure components might originate from the differences in the manners by which oleate component 
interacts with membrane bilayers. HAMLET locally inserts multiple amphiphiles in the membrane driv-
ing spontaneous curvature generation needed to drive protrusion formation such as we observe. We 
draw parallel with a qualitatively similar membrane tubulation reported for synthetic polymers present-
ing multiple amphiphilic side-chains reported previously35.
Reconciling these observations with models for interactions of oleic acid with phospholipid mem-
branes36,37, we deduce that the HAMLET-membrane interactions occur through a novel mechanism, dis-
tinct from those characterizing membrane remodeling by typical curvature-inducing scaffolding proteins 
(e.g., BAR domains and COPII)8,13, due to (1) local delivery and insertion of multiple, protein-bound 
oleate cofactors to the exoplasmic membrane leaflet and (2) a reduction in diffusive flip-flop (or translo-
cation) of the oleic acid between the bilayer leaflets. A net synergistic effect of the interplay of these two 
factors is to stabilize membrane asymmetry, driving the creation of a net area-difference between the 
www.nature.com/scientificreports/
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Figure 5. Insensitivity of healthy, differentiated cell membranes to HAMLET challenge. (A) Maintained 
membrane integrity and structure in healthy small airway epithelial cells (SAEs) after HAMLET exposure 
(35 μ M, 15 minutes). Scale Bar, 5 μ m (B) Loss of Ras proteins from the membrane (arrows). Fixed cells 
stained for Ras, RasL11B or RasL12. Scale bar, 10 μ m. (C) Quantification of Ras, RasL11B or RasL12 
staining in SAE cells treated with HAMLET or untreated control (n = 10). (D) Quantification of Ras activity 
in control untreated and HAMLET-treated SAE and A549 cells. The active Ras was pulled down with the 
Ras-binding domain of Raf1.
www.nature.com/scientificreports/
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membrane leaflets and generating an effective spontaneous curvature. These alterations in the membrane 
compositions and geometry then give rise to membrane tubulation, such as we observe. Since the phys-
ical principles underlying this membrane interaction and uptake mechanisms are not specific to HLA 
alone, and may be recapitulated by LA species variants (e.g., bovine, equine, and caprine lactalbumins), 
these results might provide a mechanistic basis for appreciating the diversity of proteolipid complexes, 
which show potential for tumoricidal activity38.
HAMLET’s interaction is driven by mechanisms distinctly different from those produced by pro-
tein crowding at the membrane surface. Unlike surface docking of proteins at high concentrations that 
generate crowding in domain-forming membranes, HAMLET is itself a meta-amphiphile consisting of 
unfolded α -lactalbumin and a discrete number of oleic acid residues. Importantly, the protein com-
ponent of HAMLET, namely, human a-lactalbumin, retains membrane-binding capacity but does not 
induce tubulation. Similarly, oleic acid alone is also incapable of generating comparable outwardly 
directed tubulation at the concentrations used (although some internal tubulation is evident). These 
lines of evidence then emphasize the critical role played by the unique, complex geometry of HAMLET. 
We have reasoned that the oleic acid cofactor, which naturally partitions within the hydrophobic core of 
the membrane, produces area difference between the two leaflets; a reduction in diffusive flip-flop (or 
translocation) of the oleic acid between the bilayer leaflets due to HLA-oleate association in HAMLET 
then drive tubule generation by well-known curvature generation mechanisms.
Membrane blebbing has been investigated as a mechanism involved in ameboid cancer cell motility, 
promoting the invasiveness of metastatic cells39. Rho and Roc dependent blebbing can be triggered in 
normal cells by the loss of p5340. In addition, in tumor cells, Src kinases activate blebbing and motil-
ity through the SH4-domain, which facilitates tumor cell invasion41–46. While motility has not been 
addressed, cell death in response to HAMLET is independent of p5347. In particular, canonical apop-
totic regulators such as caspases and Bcl-2 have also been ruled out, based on Bcl-2 overexpression and 
caspase inhibition experiments. Furthermore, in preliminary studies, the ROC kinase has not been found 
not to influence HAMLET-induced cell death. Importantly, this suggests that HAMLET circumvents 
fundamental anti-apoptotic strategies adopted by tumor cells.
These findings illustrate a more general physical mechanism for receptor-free signaling, where the 
docking and insertion of extra-cellular protein-lipid complexes may produce membrane conformations, 
which serve as surrogate signaling receptors. It appears tempting to speculate that the ability of HAMLET 
to induce and select membrane conformations to localize and initiate signaling may illustrate a more 
pervasive class of physical mechanisms for ‘’receptor-free” signaling – presumably prevalent in early 
protocells – where docking, crowding, and insertion of extra-cellular proteins modulate membrane con-
formations. The conceptual departure from the receptor-dependent lock-and-key model of signal trans-
duction, exemplified here, does not rule out the importance of specificity, but it causes us to re-evaluate 
the notion of a specific receptor as a prerequisite for cellular recognition.
Materials and Methods
Materials. 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and Rhodamine-B DOPE (lis-
samine rhodamine B 1,2-dioleyl-sn-glycero-3-phosphoethanolamine) were from Avanti Polar Lipids 
(Birmingham, AL), Oregon Green 488 1,2-dihexadecanoyl-sn-glycero-3 phosphoethanolamine (Oregon 
Green DHPE) from Life Technologies (Carlsbad, CA), Oleic acid, sodium oleate, and glucose from 
Sigma-Aldrich (Saint Louis, MO) and sucrose from EMD Chemicals (Philadelphia, PA). Rabbit anti-Ras 
(EPR3255), Rasgrp3 (AB103622), Rab3c (AB170053), and mouse anti-RasL12 (AB67622) and Rhebl1 
(AB57333) were from Abcam (Cambridge, Cambridgeshire, UK). Rabbit anti-Rap1A/B (#4938S), rabbit 
anti-Raf1 (C-12), Arl5A/5C/8 (H-113), were from Cell Signaling (Danvers, MA) and mouse anti Raf-B 
(F-7), RasL11b (5J7) and Arfgap 1/3 (G-11) from Santa Cruz (Dallas, TX). RPMI-1640 was from HYclone 
(HYCLSH30027); sodium pyruvate (11481318), non-essential amino acids (11401378) and fetal bovine 
serum (10309433) were from Fisher Scientific; gentamicin was from Life Technologies (15710049); A549 
cells (ccl-185), primary small airway epithelial cells (PCS-301-010), airway epithelial cell basal medium 
(PCS-300-030) and small airway epithelial cell growth kit (PCS-301-040) were from ATCC.
Giant unilamellar vesicle experiments. Giant vesicles were prepared by adapting the well-established 
electroformation method due to Angelova and co-workers27. Small droplets (15–25 μ L) of lipid solution 
in chloroform (2 mg/ml) were spread on an ITO substrate and allowed to dry under vacuum for 1 h. The 
dried lipid cake was then hydrated with a 300 mM sucrose solution in deionized water and sandwiched 
using a second ITO slide. GUVs were electroformed by subjecting the sandwich to A 3V AC sine-wave 
voltage at 10 Hz for 2 h followed by a 3V square wave voltage at 2 Hz for an additional 1 h. For study, 
GUV solution was diluted to a final lipid concentration of 0.01 mg/ml.
HAMLET, HLA, oleic acid, and sodium oleate were incubated at room temperature with the diluted 
GUV suspension. GUVs were incubated with 30 μ M (HAMLET and HLA) or 175 μ M (oleic acid and 
sodium oleate) solution for a period of 30 min to 2 h and imaged under a fluorescence microscope in 
spinning disk confocal configuration.
Preparation of Tumor cell lipid extract (TCLE) giant unilamellar vesicle. A549 lung carcinoma 
cell lipids were extracted into chloroform/methanol (2:1) using the Folch Method48. From the lipid 
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extract a stock solution was prepared consisting of TLCE/Rhodamine-B DOPE (98/2 by mass). Lipids 
were subsequently dried on the conductive sides of ITO slides as described above. In a modification of 
the above procedure, the lipids were then prehydrated in an oven at ~50 °C containing saturated K2SO4 
solution for ~24 hr. The slides were then assembled for electroformation with 300 mM sucrose as used 
above. The electroformation parameters were a 500 hz sine wave for 3 hours.
Flux and leakage assay. Flux assays in artificial liposomes were performed using Sodium 
Green (Invitrogen) fluorescence. Artificial liposomes were produced by mixing chloroform solu-
bilized 1,2-dioleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (DOPG, Avanti Lipids) and Egg yolk 
L-α -phosphatidylcholine (EYPG, Avanti Lipids) in a 1:1 ratio. Chloroform was removed by evaporation 
in a dry nitrogen stream and lipids where washed in anhydrous pentane. Pentane was evaporated in a dry 
nitrogen stream and the lipids where solubilized in buffer 1 (20 mM TRIS, 4 mM NaCl, 34 mM CHAPS, 
5 μ M Sodium Green, pH 7.5) via bath sonication. Following 1 h incubation, CHAPS was removed by 
centrifuge assisted gelfiltration: Sephadex G50 (Sigma-Aldrich) where swollen in Buffer 2 (20 mM TRIS, 
4 mM NaCl, 5 μ M Sodium Green, pH 7.5) and packed in Pierce Disposable Plastic columns. Lipid solu-
tion was loaded and buffer-shift was accomplished by centrifugation at 1000 × g for 1 min. Liposomes 
where prepared by seven freeze-thaw cycles using liquid N2 and a 55 °C water bath. Liposomes were 
exposed to 10 s sonication before Sodium Green was removed from the extraliposomal environment by 
centrifuge-assisted gelfiltration in buffer 3 (20 mM TRIS, 4 mM NaCl, pH 7.5). Liposomes where subse-
quently loaded into microwell plates and incubated with HAMLET, α -lactalbumin or oleate before flux 
measurements performed using a Fluostar-Optima, BMG microplate reader. Sodium Green was excited 
at 485 nm and fluorescence was continuously measured above 520 nm during a 5 min stabilization period, 
after which 200 mM NaCl was automatically added to induce Na+ influx (2 μ l buffer 4 (20 mM TRIS, 2 M 
NaCl, pH 7.5) to 200 μ l).
Leakage of GUVs consisting of POPC was further investigated with fluorophore labeled 2-NBDG; 
GUVs were electroformed in 300 mM sucrose. Prior to incubation with 30 uM HAMLET, vesicles were 
then diluted in PBS containing 58 μ M 2-NBDG in the GUV exterior to monitor leakage.
Spinning disk confocal fluorescence microscopy. Experiments were performed using Intelligent 
Imaging Innovations Maranias Digital Microscopy Workstation (3i Denver, CO) fitted with with a 
CSU-X1 spinning disk head (Yokogawa Musashino-sh, Tokyo, Japan), an Quantem512SC EMCCD cam-
era (Photometrics Tuscon, AZ), and multi-laser stack (50 mW, for illumination. Images were obtained 
using oil immersion objectives (Zeiss Fluor 40x (NA 1.3) and a Zeiss Plan-Fluor 63x (NA 1.4), Carl Zeiss 
Oberkochen, Germany) and processed using ImageJ (http://rsbweb.nih.gov/ij/) and Slidebook digital 
microscopy imaging software (3i Denver, CO).
HAMLET: characterization, production and quality control. α -Lactalbumin was purified from 
human breast milk by 25% ammonium sulphate precipitation and hydrophobic interaction chromatog-
raphy, partially unfolded and converted to HAMLET on a oleic acid-conditioned DEAE ion exchanger49. 
Human milk was obtained from individual donors, after signed informed consent. Each donor was aware 
that the samples might be used in scientific research. The samples were de-identified and steps were taken 
to protect the participants’ identities. The procedure was approved by the human ethics committee of the 
Medical Faculty, Lund University, Lund, Sweden.
Mammalian Cell Culture. Lung carcinoma cells (A549) and primary small airway epithelial cells 
(SAE cells) were procured from American Type Culture Collection (ATCC). Lung carcinoma cells 
were maintained in RPMI-1640 medium supplemented with 1 mM sodium pyruvate (Fisher Scientific), 
non-essential amino acids (1:100) (Fisher Scientific), 50 μ g/ml gentamicin (Gibco, Paisley, UK) and 
5% fetal calf serum (FCS). Small airway epithelial cells were maintained in airway epithelial cell basal 
medium (ATCC) supplemented with small airway epithelial cell growth kit (ATCC), according to ATCC 
instructions. Cells were cultured at 37 °C, 90% humidity and 5% CO2.
Confocal imaging. Lung carcinoma cells treated with HAMLET (35 μ M, 10% Alexa-HAMLET 
labeled with AlexaFluor568 or AlexaFluor488 via amine coupling according to manufacturer’s instruc-
tions (Life Technologies)). Cells were fixed with paraformaldehyde (4%), permeabilized with Triton X 
(0.25% in PBS) for 10 min and incubated with primary antibodies (1:25 dilution in 10% FCS/PBS) for 
2 h at room temperature, washed with PBS (three times) and then incubated with appropriate secondary 
antibodies conjugated to Alexa-488 (1:100 in 10% FCS/PBS, Molecular Probes). Nucleus was stained 
with DRAQ-5 (Abcam), cells were washed with PBS three times and mounted on a polylysine slides 
(Thermoscientific). Slides were examined using LSM 510 META laser scanning confocal microscope 
(Carl Zeiss). Colocalization analysis and fluorescence quantification were performed in LSM510 image 
browser software and Photoshop CS5, respectively. For quantification of Ras family proteins in lung 
carcinoma cells, individual tumor cell bleb (n = 3 to 8/cell) was outlined as region of interest (ROIs) and 
compared to cytoplasmic staining of the same cell (n = 6). The mean gray scale values were calculated 
with Photoshop CS5 and expressed as fluorescence intensity. For Ras, RasL11B and RasL12 staining in 
primary small airway epithelial cells, individual cell membrane regions (n = 10) were outlined as regions 
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of interest (ROIs), and the total fluorescence intensities were measured using LSM 510 image browser 
software.
Images were captured using LSM 510 META confocal microscope (Carl Zeiss, 40x oil immersion 
objective, 633 nm HeNe laser and 650 long-pass filter, 488 nm Argon/2 laser and 505–530 band-pass 
filter, 543 nm HeNe laser and 585–615 band-pass filter).
Live transmission light microscopy imaging. Membrane changes in lung carcinoma cells or pri-
mary small airway epithelial cells were visualized by transmission light microscopy imaging. Cells were 
seeded on a glass cover slip and allowed to partially adhere to the glass surface for 10 min at room tem-
perature prior to HAMLET treatment (35 μ M). Immediate changes in cell morphology were captured 
with LSM 510 META confocal microscope (Carl Zeiss) using 40× oil immersion objective.
Membrane localization of HAMLET. Lung carcinoma cells or primary small airway epithelial cells 
in suspension were treated with HAMLET (35 μ M, 10% Alexa-HAMLET) at 4 °C for 30 min, unbound 
HAMLET was washed with cold PBS and images were acquired with LSM 510 META confocal micro-
scope (Carl Zeiss) using 40x oil immersion objective, 488 nm Argon/2 laser and 505–530 band-pass 
filter).
Ras activity measurements. Lung carcinoma cells or primary small airway epithelial cells were 
treated with HAMLET. Cell lysates were prepared and 1 mg/ml of protein was used for pull down of 
active Ras complexes with GST tagged RBD. Immunoprecipitation was done according to manufactures 
instructions (Thermoscientific). Immunoprecipitated samples were separated on Bis-Tris (4–12%) SDS 
gel (Invitrogen), the separated proteins were blotted to polyvinylidine fluoride (PVDF) membranes (GE 
Health Care) and probed with mouse anti-Ras antibody (1:200 dilution in 3% BSA, Thermoscientific) 
for 2 h at room temperature. PVDF membranes were washed with PBS Tween, 0.1% (PBST) and probed 
with secondary antibody, goat anti-mouse-HRP (1:4000 dilution in 5% milk, DAKO) for 1 h at room 
temperature followed by washing three times with PBST. Active and total Ras were visualized using ECL 
chemiluminescence reagent (GE Healthcare).
Statistical analysis. Pearson product-moment correlation coefficient, R, was performed for 
co-localization analysis. Student’s T-test was used to calculate statistical significance of the experiments 
(Microsoft Excel).
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